In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Best Industries Inc.

Latest From Best Industries Inc.

Resurrecting Cordis

Having built up a $500 million business with the only approved coronary stent on the US market, Johnson & Johnson's Cordis watched virtually all of it slip away to competitors who came to market with superior products. But now the company is back, with the introduction of a new line of stents, expansion into a broad line of cardio- and vascular products, and a head start in one of the most promising device areas: drug-coated stents. Cordis' goal: to be number one again.

Medical Device Strategy

Novoste: Proving the Exception

Novoste is out to show that the changing device world still has room, in the right market, for a small single-product company to succeed against larger competitors.

Medical Device Strategy

Restenosis: Multi-Billion-Dollar Market Tempts Many

A variety of approaches are being used to combat the problem of restenosis following angioplasty. In addition to separate drug and device efforts, several companies are working on drug-device collaborations to prevent restenosis.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices